HR 1862 · 107th Congress 2001–2003, ended

Greater Access to Affordable Pharmaceuticals Act of 2001

Introduced May 16, 2001 Originated House Sponsor Sherrod Brown D-OH

Latest action · May 7, 2002 Sponsor introductory remarks on measure. (CR H2110)

Progress

Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.

IntroducedMay 16, 2001
Passed HouseNot reached
Passed SenateNot reached
To the PresidentNot reached
Became lawNot reached

Summary

Greater Access to Affordable Pharmaceuticals Act of 2001 - Amends the Federal Food, Drug, and Cosmetic Act to provide for an accelerated date of approval for a generic drug application.

Allows a drug to be considered a bioequivalent to a listed drug if the effects of such drug and the listed drug do not show a significant difference based on certain tests or studies.

Sets forth requirements concerning the filing of a citizen petition review.

Revises provisions concerning: (1) abbreviated new drug applications and new drug applications with respect to the time required for approval and the certification that a patent is invalid or will not be infringed; and (2) filing an application.

Requires a report concerning the extent to which this Act has: (1) has enabled products to come to market in a fair and expeditious manner, consistent with the rights of patent owners under intellectual property law; and (2) has promoted lower prices of drugs and greater access to drugs through price competition..

Cosponsors 62

Members who signed on, in the order they did. Signatures ran from May 16, 2001 to Sep 26, 2002; 10 are original cosponsors, there from the day it was introduced.

Seat	Cosponsor		Signed on
D-MA	Barney Frank	Original	May 16, 2001
D-MI	Bart Stupak	Original	May 16, 2001
I-VT	Bernard Sanders	Original	May 16, 2001
D-NJ	Frank Pallone, Jr.	Original	May 16, 2001
R-MO	Jo Ann Emerson	Original	May 16, 2001
D-ME	John Elias Baldacci	Original	May 16, 2001
D-FL	Karen L. Thurman	Original	May 16, 2001
D-OH	Marcy Kaptur	Original	May 16, 2001
D-MS	Ronnie Shows	Original	May 16, 2001
D-ME	Thomas H. Allen	Original	May 16, 2001
D-NY	Carolyn McCarthy		May 25, 2001
D-OR	Peter A. DeFazio		May 25, 2001
D-MI	David E. Bonior		Jun 7, 2001
D-MA	James P. McGovern		Jun 7, 2001
D-RI	James R. Langevin		Jun 7, 2001
R-OH	Steven C. LaTourette		Jun 7, 2001
R-PA	Todd Russell Platts		Jun 7, 2001
D-CA	Bob Filner		Jun 12, 2001
D-OH	Dennis J. Kucinich		Jun 12, 2001
D-MI	James A. Barcia		Jun 12, 2001
D-TX	Martin Frost		Jun 12, 2001
D-PA	Robert A. Brady		Jun 12, 2001
D-NY	Louise McIntosh Slaughter		Jun 26, 2001
D-WV	Nick J. Rahall II		Jun 26, 2001
D-FL	Peter Deutsch		Jun 26, 2001
D-WI	Thomas M. Barrett		Jun 26, 2001
D-IL	Rod R. Blagojevich		Jun 28, 2001
D-GA	Cynthia A. McKinney		Jul 11, 2001
D-MA	John F. Tierney		Jul 11, 2001
D-CA	Lucille Roybal-Allard		Jul 11, 2001
D-MI	Dale E. Kildee		Jul 17, 2001
D-NY	Maurice D. Hinchey		Jul 17, 2001
R-NE	Doug Bereuter		Oct 2, 2001
D-PA	Frank Mascara		Oct 2, 2001
D-NY	Nita M. Lowey		Oct 2, 2001
D-OH	Ted Strickland		Nov 6, 2001
D-NY	Jerrold Nadler		Feb 13, 2002
D-IN	Julia Carson		Feb 13, 2002
D-MI	Lynn N. Rivers		Feb 13, 2002
D-WA	Brian Baird		Apr 10, 2002
D-MA	John W. Olver		Apr 10, 2002
D-NY	Joseph Crowley		Apr 10, 2002
D-CT	Rosa L. DeLauro		Apr 10, 2002
D-VI	Donna M. Christensen		May 22, 2002
D-DC	Eleanor Holmes Norton		May 22, 2002
R-TN	John J. Duncan, Jr.		May 22, 2002
D-NM	Tom Udall		May 22, 2002
R-SD	John Thune		Jun 4, 2002
D-CA	Lynn C. Woolsey		Jun 20, 2002
D-AR	Marion Berry		Jun 20, 2002
D-WI	Ron Kind		Jun 20, 2002
R-GA	Jack Kingston		Jul 9, 2002
D-NY	Steve Israel		Jul 9, 2002
D-AR	Mike Ross		Jul 22, 2002
D-RI	Patrick J. Kennedy		Jul 22, 2002
D-GU	Robert A. Underwood		Sep 11, 2002
D-CA	Adam B. Schiff		Sep 24, 2002
D-CA	Barbara Lee		Sep 24, 2002
D-NY	Carolyn B. Maloney		Sep 24, 2002
D-PA	Paul E. Kanjorski		Sep 24, 2002
D-WI	Tammy Baldwin		Sep 24, 2002
D-NY	Michael R. McNulty		Sep 26, 2002

Committees 1

Where it was sent and what each committee and subcommittee did with it, in order.

Chamber	Committee	What it did
House	Energy and Commerce Committee	Referred May 16, 2001
	Health Subcommittee	Referred Jun 1, 2001

Actions 4

Everything that happened, newest first.

May 7, 2002Sponsor introductory remarks on measure. (CR H2110)
Jun 1, 2001Referred to the Subcommittee on Health.
May 16, 2001Introduced in House
May 16, 2001Referred to the House Committee on Energy and Commerce.

In the Congressional Record 6

Days the Record’s own index lists this bill, newest first, with the pages and the members it names. Pages starting H are the House, S the Senate, E Extensions of Remarks.

Where	In the Record	Members	Date
House	Discharge petition H7898	—	Oct 11, 2002
House	Discharge petition H7019	—	Oct 3, 2002
House	Discharge petition H6778	—	Sep 26, 2002
House	Debate and remarks H6377, H6378, H6379, H6380, H6381, H6387, H6390, H6393, H6394, H6398Discharge petition H6420	Betty McCollum D-MN, Christopher Cox R-CA, Frank Pallone, Jr. D-NJ, Gerald D. Kleczka D-WI, Janice D. Schakowsky D-IL, Karen L. Thurman D-FL, Lynn C. Woolsey D-CA, Martin Frost D-TX, Maurice D. Hinchey D-NY, Sherrod Brown D-OH	Sep 19, 2002
House	Debate and remarks H6268	Sherrod Brown D-OH	Sep 17, 2002

Show all 6 days

Research

What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.

Printed hearings 2

Hearings whose printed record names this bill, newest first: hearings on it, and wider hearings where it came up.

Number	Hearing	Committee	Held
Serial No. 107-140	EXAMINING ISSUES RELATED TO COMPETITION IN THE PHARMACEUTICAL MARKETPLACE: A REVIEW OF THE FTC REPORT, GENERIC DRUG ENTRY PRIOR TO PATENT EXPIRATION146 pages	Energy and Commerce Committee	Oct 9, 2002
Serial No. 107-34	RECENT DEVELOPMENTS WHICH MAY IMPACT CONSUMER ACCESS TO, AND DEMAND FOR, PHARMACEUTICALS239 pages	Energy and Commerce Committee	Jun 13, 2001

CRS reports 1

Congressional Research Service work that CRS links to this bill or the law it became, newest first.

Cite it 1

Products on other subjects that cite it, usually among other measures.

Product	Title	Kind	Published
97-856	The Discharge Rule in the House: Recent Use in Historical Context Archived	Report	Apr 17, 2003

Related bills 2

Companion bills and other measures the record links to this one.

Bill	Title	Relationship	Latest action
HRES 517	Providing for consideration of the bill (H.R. 1862) to amend the Federal Food, Drug, and Cosmetic Act to provide greater access to affordable pharmaceuticals.	Procedurally related	Sep 19, 2002
S 812	Greater Access to Affordable Pharmaceuticals Act of 2002	Identical bill	Sep 4, 2002

Titles 2

Every title it has carried, official and short, at each stage.

Official Title as Introduced: To amend the Federal Food, Drug, and Cosmetic Act to provide greater access to affordable pharmaceuticals.
Short Titles as Introduced: Greater Access to Affordable Pharmaceuticals Act of 2001

Subjects

Assigned by the Library of Congress. Policy area: Health.

Text 1

Each version as it was printed, newest first.

May 16, 2001Introduced in House

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

$1 $5 $10

Processed by Stripe in a separate window. LegiList never sees card details.

Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.